Global Chikungunya Fever Market - Overview
Chikungunya fever is a disease caused by mosquito bites. It is an RNA virus that belongs to the
alphavirus genus of the family Togaviridae. The disease is transmitted via human to human by
the bites of female mosquitoes that are infected. The most commonly involved mosquitoes are
Aedes albopictus and Aedes aegypti. Symptoms includes nausea, headache, rashes, fatigue and
muscle pain. There are no drug available for the treatment of Chikungunya fever.
Moreover, treatment are available for relieving the symptoms of this disease. In allopathy, the
use of optimal analgesics and anti-pyretics are preferred treatment option. While, for
homeopathy and ayurveda specific treatment procedures are employed. As per the World
Health Organization (WHO), the disease mostly occurs in Asian countries such as the Indian
subcontinent and other African regions. Nevertheless, there was major outbreak of this disease
in 2015 that affected several countries in the Americas region. Incidents such as this is
projected to boost the market growth across the globe during the forecasted period.
Request Sample Copy:
Globally, more than 60 countries had reported Chikungunya fever cases for all regions including
Africa continents, Americas, Europe, and Asia Oceanic. According to the World Health
Organization in 2016, there were 349 936 suspected with more than 146 914 laboratory
confirmed cases of chikungunya reported to the (Pan American Health Organization) PAHO
regional office. Countries such as Brazil reported the most severe cases with 265 000 suspected
cases followed by Bolivia and Colombia at 19 000 suspected cases.
The global chikungunya fever market is expected to grow at a CAGR of 5.8% during the forecast
Global Chikungunya Fever Market - Regional Analysis
The global chikungunya fever market is divided into four regions namely Americas, Europe, Asia
Pacific and the Middle East and Africa.